1355 — Biosysen Cashflow Statement
0.000.00%
Last trade - 00:00- HK$379.39m
- HK$441.74m
- HK$51.31m
Annual cashflow statement for Biosysen, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.15 | -16.1 | -58.7 | -37.1 | -45.4 |
| Depreciation | |||||
| Non-Cash Items | 4.94 | 5.59 | 64 | 25 | 14.8 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.5 | -10.8 | 0.686 | 12.3 | -15.9 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Payable / Accrued Expenses | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 30.4 | 9.35 | 35.2 | 24.3 | -32.7 |
| Capital Expenditures | -16.3 | -2.94 | -0.648 | -0.255 | -16.9 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0.029 | 0.01 | 0.004 | 0.005 | -14.9 |
| Acquisition of Business | |||||
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -16.3 | -2.93 | -0.644 | -0.25 | -31.8 |
| Financing Cash Flow Items | — | — | — | — | -4.88 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -19.8 | -19 | -34.9 | -12 | 53 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -5.67 | -11.9 | -0.22 | 11.6 | -11.4 |